跳至主要内容
临床试验/NL-OMON44188
NL-OMON44188
已完成
不适用

Pilot study: Respiratory microbiome analysis by the IS-pro technology - The Maastricht Respiratory Microbiome Study

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 21 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
community of microorganisms
发起方
Medisch Universitair Ziekenhuis Maastricht
入组人数
21
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
2017年1月17日
最后更新
去年
研究类型
Observational invasive

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

入排标准

入选标准

  • \* Diagnosis of COPD stages I\-IV, class A\-D, as defined by the Global initiative for chronic Obstructive Lung Disease (GOLD);
  • \* Patients must be planned to undergo a bronchoscopy;
  • \* Patients must be able to complete questionnaires;
  • \* Patients must sign and date an informed consent prior to inclusion.

排除标准

  • \* Chronic use of oral corticosteroids \> 10 mg/day;
  • \* Investigator\*s uncertainty about the willingness or ability of the patient to comply with the protocol requirements, e.g. not smoking 6 hours before and fasting two hours before sputum induction;
  • \* Patients with mental conditions rendering them unable to understand the nature, scope, and possible consequences of the study;
  • \* Patients unlikely to comply with the protocol, e.g. uncooperative attitude, and unlikelihood of completing the study (not able to attend all three visits).

结局指标

主要结局

未指定

相似试验